Beng-Choon Ho

Beng-Choon Ho

Auto-generated profile, based on publicly available information

Beng-Choon Ho

Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, IA, USA

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 March 2020 in Science
Verified
Journal Article
Closed access
PDF file
KGKatrina Grasby
Katrina Grasby
NJNeda Jahanshad
Neda Jahanshad
JPJodie Painter
Jodie Painter
LCLucía Colodro Conde
Lucía Colodro Conde
JBJanita Bralten
Janita Bralten
EGEnhancing NeuroImaging Genetics through Meta-Analysis Consortium (ENIGMA)—Genetics working group
Enhancing NeuroImaging Genetics through Meta-Analysis Consortium (ENIGMA)—Genetics working group
INTRODUCTION: The cerebral cortex underlies our complex cognitive capabilities. Variations in human cortical surface area and thickness are associated with neurological, psychological, and behavioral traits and can be measured in vivo by magnetic resonance imaging (MRI). Studies in model organisms have identified genes that influence cortical structure, but little is known about common genetic variants that affect human cortical structure. RATIONALE: To identify genetic variants associated with human cortical structure at both global and regional levels, we conducted a genome-wide association meta-analysis of brain MRI data from 51,665 individuals across 60 cohorts. We analyzed the surface area and average thickness of the whole cortex and 34 cortical regions with known functional specializations. RESULTS: We identified 369 nominally genome-wide significant loci ( P < 5 × 10 −8 ) associated with cortical structure in a discovery sample of 33,992 participants of European ancestry. Of the 360 loci for which replication data were available, 241 loci influencing surface area and 66 influencing thickness remained significant after replication, with 237 loci passing multiple testing correction ( P < 8.3 × 10 −10 ; 187 influencing surface area and 50 influencing thickness). Common genetic variants explained 34% (SE = 3%) of the variation in total surface area and 26% (SE = 2%) in average thickness; surface area and thickness showed a negative genetic correlation ( r G = −0.32, SE = 0.05, P = 6.5 × 10 −12 ), which suggests that genetic influences have opposing effects on surface area and thickness. Bioinformatic analyses showed that total surface area is influenced by genetic variants that alter gene regulatory activity in neural progenitor cells during fetal development. By contrast, average thickness is influenced by active regulatory elements in adult brain samples, which may reflect processes that occur after mid-fetal development, such as myelination, branching, or pruning. When considered together, these results support the radial unit hypothesis that different developmental mechanisms promote surface area expansion and increases in thickness. To identify specific genetic influences on individual cortical regions, we controlled for global measures (total surface area or average thickness) in the regional analyses. After multiple testing correction, we identified 175 loci that influence regional surface area and 46 that influence regional thickness. Loci that affect regional surface area cluster near genes involved in the Wnt signaling pathway, which is known to influence areal identity. We observed significant positive genetic correlations and evidence of bidirectional causation of total surface area with both general cognitive functioning and educational attainment. We found additional positive genetic correlations between total surface area and Parkinson’s disease but did not find evidence of causation. Negative genetic correlations were evident between total surface area and insomnia, attention deficit hyperactivity disorder, depressive symptoms, major depressive disorder, and neuroticism. CONCLUSION: This large-scale collaborative work enhances our understanding of the genetic architecture of the human cerebral cortex and its regional patterning. The highly polygenic architecture of the cortex suggests that distinct genes are involved in the development of specific cortical areas. Moreover, we find evidence that brain structure is a key phenotype along the causal pathway that leads from genetic variation to differences in general cognitive function. Identifying genetic influences on human cortical structure.: ( A ) Measurement of cortical surface area and thickness from MRI. ( B ) Genomic locations of common genetic variants that influence global and regional cortical structure. ( C ) Our results support the radial unit hypothesis that the expansion of cortical surface area is driven by proliferating neural progenitor cells. ( D ) Cortical surface area shows genetic correlation with psychiatric and cognitive traits. Error bars indicate SE. IMAGE CREDITS: (A) K. COURTNEY; (C) M. R. GLASS

1 February 2010 in Biological Psychiatry
Verified
Journal Article
Closed access
NANancy C. Andreasen
Nancy C. Andreasen
MPMarcus Pressler
Marcus Pressler
PNPeggy C. Nopoulos
Peggy C. Nopoulos
DMDel Miller
Del Miller
BHBeng-Choon Ho
Beng-Choon Ho

7 February 2011 in Archives of General Psychiatry
Verified
Journal Article
Open access
PDF file
BHBeng-Choon Ho
Beng-Choon Ho
NANancy C. Andreasen
Nancy C. Andreasen
SZSteven Ziebell
Steven Ziebell
RPRonald Pierson
Ronald Pierson
VMVincent A. Magnotta
Vincent A. Magnotta
Schizophrenia, a common mental illness affecting 1% of the worldwide population, remains a leading cause of chronic disability among young adults.1 Antipsychotic medications are the mainstay of treatment because there is strong empirical evidence that these drugs reduce psychotic symptomsand relapse rates in schizophrenia patients.2 Even though the majority of patients receive antipsychotics and benefit from reduction in psychotic symptoms, many patients continue to have negative symptoms, cognitive impairments, and progressive brain tissue loss.3-13 The causes underlying these brain abnormalities are unclear and have been a focus of much debate14,15 and many literature reviews.16,17

8 January 2014 in Brain Imaging and Behavior
Verified
Journal Article
Open access
PDF file
PTPaul M. Thompson
Paul M. Thompson
JSJason L. Stein
Jason L. Stein
SMSarah E. Medland
Sarah E. Medland
DHDerrek P. Hibar
Derrek P. Hibar
AVAlejandro Arias Vasquez
Alejandro Arias Vasquez
WDWayne Drevets
Wayne Drevets
The Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) Consortium is a collaborative network of researchers working together on a range of large-scale studies that integrate data from 70 institutions worldwide. Organized into Working Groups that tackle questions in neuroscience, genetics, and medicine, ENIGMA studies have analyzed neuroimaging data from over 12,826 subjects. In addition, data from 12,171 individuals were provided by the CHARGE consortium for replication of findings, in a total of 24,997 subjects. By meta-analyzing results from many sites, ENIGMA has detected factors that affect the brain that no individual site could detect on its own, and that require larger numbers of subjects than any individual neuroimaging study has currently collected. ENIGMA’s first project was a genome-wide association study identifying common variants in the genome associated with hippocampal volume or intracranial volume. Continuing work is exploring genetic associations with subcortical volumes (ENIGMA2) and white matter microstructure (ENIGMA-DTI). Working groups also focus on understanding how schizophrenia, bipolar illness, major depression and attention deficit/hyperactivity disorder (ADHD) affect the brain. We review the current progress of the ENIGMA Consortium, along with challenges and unexpected discoveries made on the way.


1 September 2013 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Open access
PFPaolo Fusar-Poli
Paolo Fusar-Poli
RSR. Smieskova
R. Smieskova
MKM.J. Kempton
M.J. Kempton
BHB.C. Ho
B.C. Ho
NAN.C. Andreasen
N.C. Andreasen
SBStefan Borgwardt
Stefan Borgwardt
Antipsychotic treatment is the first-line treatment option for schizophrenia. Individual studies suggested they can significantly affect brain structure and account for progressive brain changes observed during the illness. To quantitatively examine the effect of antipsychotics as compared to illness related factors on progressive brain changes in schizophrenia. Electronic databases were searched until April 2012. All magnetic resonance imaging studies reporting progressive brain changes in schizophrenia subjects and antipsychotic exposure were retrieved. 30 longitudinal MRI studies with antipsychotic administration in schizophrenia patients met the inclusion criteria. Brain volumes before and after antipsychotic exposure, duration of illness, severity of psychotic symptoms as well as demographic, clinical, and methodological variables were extracted from each publication, or obtained directly from its authors. The overall sample was of 1046 schizophrenia patients and 780 controls for a median duration of follow-up of 72.4 weeks. At baseline, patients showed significant whole brain volume reductions and enlarged lateral ventricle (LV) volumes compared to controls. No baseline volumetric abnormalities were detected in the gray matter volumes (GMV), white matter volumes, cerebrospinal fluid and caudate nucleus. Longitudinally, there were progressive GMV decreases and LV enlargements in patients but not in controls. The GMV decreases were inversely correlated with cumulative exposure to antipsychotic treatments, while no effects were observed for duration of illness or illness severity. Schizophrenia is characterized by progressive gray matter volume decreases and lateral ventricular volume increases. Some of these neuroanatomical alterations may be associated with antipsychotic treatment.